Gilead Sciences is factoring potential savings to hospitals into its pricing decision for its promising COVID-19 treatment, but hospitals say savings are hard to quantify this early.
from Section Page News - Modern Healthcare https://ift.tt/309kgpw
via IFTTT
No comments:
Post a Comment